GlassScriptPrepare for your visit
John F Decarli
Internal Medicine · Wilmington, DE · NPI 1063404044
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,415.16
in general payments reported to CMS, 2019-2025 · $225 in 2025
The $225 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Smith+Nephew, INC. $460.30
- Abbvie INC. $162.39
- Paratek Pharmaceuticals, INC. $124.99
- Kci USA, INC. $120.35
- Reapplix INC. $89.99
- Kerecis Limited $63.15
Drugs and devices associated with these payments
Collagenase Santyl Nuzyra Kerecis Surgiclose Avycaz 3c Patch Kit - Box Teflaro Activ.A.C. Regranex Cutimed Promogran Prisma Dalvance Kerecis Graftguide
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw John Decarli listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/138172/john-f-decarli